LLY
Drug Manufacturers - General · Healthcare
Head of Investor Relations
Head of Investor Relations
ELI LILLY & Co (LLY)Equibles does not estimate personal net worth.
Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.
Get LLY alertsMike Safar is recorded as Head of Investor Relations at ELI LILLY & Co (LLY). Mike Safar has spoken on 1 earnings call across 1 company, most recently for ELI LILLY & Co on August 5, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.
“Joining me on today's call are Dave Ricks, Lilly's Chair and CEO, Lucas Montarse, Chief Financial Officer, Dr. Dan Skavronsky, Chief Scientific and Product Officer, Adrian Brown, President of Lilly Immunology, Dr. Carol Ho, President of Lilly Neuroscience, Ilya Ufa, President of Lilly USA and Global Customer…”
LLY
Drug Manufacturers - General · Healthcare
Head of Investor Relations